← Leaderboards
Dobrin Nedelkov
Intrinsic Bioprobes, Inc.
$5,722,924
Attributed
$5,722,924
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,722,924 · 10
By mechanism
R44$1,612,239 · 1
R43$1,242,351 · 5
N43$983,112 · 1
R33$869,794 · 1
U54$868,398 · 1
R21$147,030 · 1
Top collaborators
No co-investigators on record.
Most similar at Intrinsic Bioprobes, Inc.
Same institution · by research overlap
- Randall W Nelson$7,963,343
- Urban A Kiernan$3,472,196
Others in their field
Top investigators on “Detection”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Francis L Halzen · University Of Wisconsin-Madison$243,423,219
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Richard A Gibbs · Baylor College Of Medicine$209,716,260
- Richard K. Wilson · Washington University$206,265,868
- Craig B Thompson · Sloan-Kettering Inst Can Research$156,512,301
Research focus
DetectionSamplingAlzheimer&AposBasePlasmaCostBiologicalAntibodiesAdoptedTechnologyComplexImmunoassayLiquid SubstanceProteinsMaldi-Tof Mass SpectrometryInstrumentationPerformanceBontoxilysinCost EffectiveBloodBiothreatBotulinum ToxinsDevicesCohort
Grant awards (17)
Clusterin glycosylation as diagnostic and prognostic biomarker for Alzheimer's disease$384,767
R43 · FY2023 · AG · contact PI
Immunoplate-MALDI MS platform and assays$256,158
R43 · FY2022 · GM · contact PI
ApoE isoform-specific glycosylation as diagnostic and prognostic biomarker of Alzheimer's disease$250,562
R43 · FY2020 · AG · contact PI
Clinical mass spectrometry test for apolipoprotein C-III proteoforms$153,545
R43 · FY2018 · GM · contact PI
Benchtop Device for Detection of BoNT in Clinical Samples$216,120
U54 · FY2013 · AI · contact PI
Benchtop Device for Detection of BoNT in Clinical Samples$4,530
U54 · FY2012 · AI · contact PI
Benchtop Device for Detection of BoNT in Clinical Samples$153,842
U54 · FY2011 · AI · contact PI
Benchtop Device for Detection of BoNT in Clinical Samples$246,298
U54 · FY2010 · AI · contact PI
Multiplex Mass Spectrometric Immunoassays$983,112
N43 · FY2009 · CA · contact PI
Benchtop Device for Detection of BoNT in Clinical Samples$247,608
U54 · FY2009 · AI · contact PI
Quantitative Mass Spectrometric Immunoassays for Population Proteomics$197,319
R43 · FY2009 · RR · contact PI
Development of SPR/MS protein array platform$364,455
R33 · FY2007 · RR · contact PI
Development of SPR/MS protein array platform$505,339
R33 · FY2006 · RR · contact PI
Development of SPR/MS protein array platform$147,030
R21 · FY2005 · RR
Affinity-based Mass Spectrometry Protein Assays$592,262
R44 · FY2004 · CA
Affinity-based Mass Spectrometry Protein Assays$890,658
R44 · FY2003 · CA
Affinity-based Mass Spectrometry Protein Assays$129,319
R44 · FY2003 · CA